GW&K Investment Management LLC Acquires 9,228 Shares of K2M Group Holdings Inc (NASDAQ:KTWO)

GW&K Investment Management LLC lifted its holdings in shares of K2M Group Holdings Inc (NASDAQ:KTWO) by 1.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 484,219 shares of the medical device company’s stock after buying an additional 9,228 shares during the quarter. GW&K Investment Management LLC owned about 1.12% of K2M Group worth $8,716,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Macquarie Group Ltd. increased its holdings in K2M Group by 0.3% during the 2nd quarter. Macquarie Group Ltd. now owns 200,656 shares of the medical device company’s stock worth $4,888,000 after acquiring an additional 581 shares during the period. Wells Fargo & Company MN increased its holdings in K2M Group by 0.9% during the 2nd quarter. Wells Fargo & Company MN now owns 63,322 shares of the medical device company’s stock worth $1,542,000 after acquiring an additional 590 shares during the period. Legal & General Group Plc increased its holdings in K2M Group by 41.4% during the 2nd quarter. Legal & General Group Plc now owns 9,561 shares of the medical device company’s stock worth $232,000 after acquiring an additional 2,798 shares during the period. Gabelli Funds LLC increased its holdings in K2M Group by 28.0% during the 3rd quarter. Gabelli Funds LLC now owns 18,300 shares of the medical device company’s stock worth $388,000 after acquiring an additional 4,000 shares during the period. Finally, BNP Paribas Arbitrage SA increased its holdings in K2M Group by 5,175.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock worth $109,000 after acquiring an additional 4,399 shares during the period. Institutional investors own 98.88% of the company’s stock.

A number of research firms recently weighed in on KTWO. Needham & Company LLC decreased their target price on shares of K2M Group from $27.00 to $26.00 and set a “strong-buy” rating on the stock in a report on Thursday, November 2nd. BidaskClub lowered shares of K2M Group from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Oppenheimer reaffirmed a “buy” rating and set a $24.00 target price on shares of K2M Group in a report on Friday, November 10th. Barclays reaffirmed a “buy” rating and set a $25.00 target price on shares of K2M Group in a report on Tuesday, January 9th. Finally, Zacks Investment Research lowered shares of K2M Group from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $24.50.

Shares of K2M Group Holdings Inc (KTWO) traded up $0.28 during trading hours on Wednesday, hitting $18.82. 141,165 shares of the stock were exchanged, compared to its average volume of 314,080. The company has a market cap of $802.01, a price-to-earnings ratio of -19.40 and a beta of 1.47. K2M Group Holdings Inc has a 1 year low of $16.44 and a 1 year high of $25.99. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/gwk-investment-management-llc-acquires-9228-shares-of-k2m-group-holdings-inc-ktwo-2.html.

K2M Group Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Institutional Ownership by Quarter for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply